| Category : |
API |
| CAS No. : |
775304-57-9 |
| Synonyms : |
3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic Acid; Ataluren_x005fPCT 124; 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]-benzoic Acid |
| Molecular Formula : |
C15H9FN2O3 |
| Assay : |
≥99.0% |
| Specification : |
Pharma grade |
| Appearance : |
White powder |
| Application : |
Ataluren is an investigational treatment being developed to treat Duchenne muscular dystrophy (DMD) resulting from a nonsense mutation in the dystrophin gene in ambulatory patients aged 2 years and older, and Becker muscular dystrophy (BMD). |
| Packaging Details : |
25 Kgs/Drum |
| Delivery Detail : |
1-2 Weeks |
| Storage : |
Store in a tightly sealed container in a cool dry place away from heat and Light |
| Shelf life : |
2 Year |
